S06445 Summary:

BILL NOS06445
 
SAME ASSAME AS A08628
 
SPONSORHANNON
 
COSPNSR
 
MLTSPNSR
 
Amd S6810, Ed L
 
Relates to requirements for electronic prescribing software under the medical assistance program; prohibits the use of advertising or messaging in such software, requires such software to include a means for prior authorization approval; prohibits use of certain information relating to a patient's benefits plan.
Go to top    

S06445 Actions:

BILL NOS06445
 
02/09/2012REFERRED TO HIGHER EDUCATION
Go to top

S06445 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S06445 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6445
 
                    IN SENATE
 
                                    February 9, 2012
                                       ___________
 
        Introduced  by  Sen.  HANNON -- read twice and ordered printed, and when
          printed to be committed to the Committee on Higher Education
 
        AN ACT to amend the education law, in relation to electronic prescribing
          software
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 

     1    Section  1.  Section  6810 of the education law is amended by adding a
     2  new subdivision 10 to read as follows:
     3    10. All electronic prescribing software used in this state  including,
     4  without  limitation,  electronic prescribing software for which prescri-
     5  bers and pharmacies receive payments pursuant to section  three  hundred
     6  sixty-seven-a of the social services law shall:
     7    (a) transmit to a prescriber only electronic communications consistent
     8  with  the  product  label  except  where such communication relates to a
     9  review article or editorial comment in a  major  peer  reviewed  profes-
    10  sional  journal,  supported  by  scientific  evidence and that meets the
    11  federal food and drug administration requirements for advertising  phar-

    12  maceutical products;
    13    (b)  not  use  any  means or permit any other person to use any means,
    14  including, but not limited to, advertising, instant messaging, and  pop-
    15  up  ads,  to  influence or attempt to influence, through economic incen-
    16  tives or otherwise, the prescribing decision of  a  prescribing  practi-
    17  tioner  at  the point of care or any such means triggered or in specific
    18  response to the input, selection, or any act of  a  prescribing  practi-
    19  tioner  or  his  or her agent in prescribing a certain pharmaceutical or
    20  directing a patient to a certain pharmacy;
    21    (c) not show information regarding a payor's formulary, co-payment  or
    22  benefit  plan  in any way that precludes or makes more difficult the act

    23  of a prescribing practitioner or patient selecting any particular  phar-
    24  macy or pharmaceutical; and
    25    (d) make available means to request a prior authorization approval and
    26  receive prior authorization and step therapy criteria and approval elec-
    27  tronically  on  the  day the prescription is issued as established via a
    28  standardized format to be created by the board of pharmacy.
    29    § 2. This act shall take effect immediately.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13447-01-1
Go to top